The Latest Cardiac and Vascular News
Proceeds to Fund the Company’s Worldwide Commercial Expansion Series D fundraising led by MicroPort YOKNEAM, Israel–(BUSINESS WIRE)–Rapid Medical, a company focused on the development of responsive, adjustable neurovascular devices, announced today that it has completed an oversubscribed Series D financing of $50M. The proceeds will be used to support the […]
SNOQUALMIE, Wash.–(BUSINESS WIRE)–Spacelabs Healthcare (the “Company” or “Spacelabs”), a division of OSI Systems, Inc. (“OSI Systems”) (NASDAQ: OSIS), today announced the release of Lifescreen™ Pro event screening system. Lifescreen Pro expands the Company’s non-invasive cardiology offerings, which include Spacelabs Pathfinder SL ambulatory ECG analysis system. Building on 40 years of technology, design, […]
Confluent Medical Technologies Announces Expansion of the Confluent Costa Rica Manufacturing Location To Meet Growing Demand in Nitinol Processing & Specialized Catheters SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Confluent Medical Technologies (Confluent), today announced a significant expansion of their Costa Rica manufacturing by adding a new facility to accommodate the increase in customer demand […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a real-world optical coherence tomography (OCT) imaging study of coronary OAS patients were released at EuroPCR 2021. […]
HONG KONG, May 20, 2021 /PRNewswire/ — OrbusNeich® Medical Company Ltd. and P&F Products & Features®, under the joint partnership OrbusNeich P&F, today announced that the TricValve® Transcatheter Bicaval Valves System has received CE mark approval. The TricValve® Transcatheter Bicaval Valve (bioprosthesis) is developed for the treatment of caval reflux present in cases of […]
Recardio Inc., a clinical-stage life science company focusing on regenerative therapies for cardiovascular diseases, announced the completion of its Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction. SAN FRANCISCO, May 19, 2021 /PRNewswire/ — The clinical study was designed to evaluate […]
WASHINGTON, May 20, 2021 /PRNewswire/ — MCRA, LLC, a leading medical device and biologics advisory firm and clinical research organization (CRO) integrating US and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, and Quality Assurance, is pleased to announce the hiring of Fernando Aguel as Vice President, Heart Failure & Circulatory Support Regulatory Affairs. Fernando […]
Proven CFO with extensive financial leadership and commercialization experience, including multiple publicly listed life sciences companies DURHAM, N.C., May 19, 2021 (GLOBE NEWSWIRE) — Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the appointment of Dale Sander as Chief Financial […]
Concord, NC, May 20, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Hydromer, Inc. (the “Company”) (HYDI:OTC) is proud to announce it has been selected as the key coatings and services partner for Avinger, Inc.’s intravascular image-guided, catheter-based systems for diagnosis and treatment of patients with Peripheral Artery Disease (PAD). Avinger’s best-in class product […]
MCT is added to the list of cardiac monitoring capabilities on a single platform including physiological parameter monitoring SAN JOSE, Calif.–(BUSINESS WIRE)–VitalConnect®, Inc., a leader in remote and in-hospital monitoring biosensor technology, announced today it has launched its VitalPatch RTM mobile cardiac telemetry (MCT) solution. The launch of the MCT […]
